No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Pharmaceuticals
Yifan Pharmaceutical Co., Ltd. engages in the research, development, production, sale of pharmaceutical products, active pharmaceutical ingredients and polymer materials. It provides blood tumors, gynecology, pediatrics, skin, orthopedic drugs, phosphate buffered saline, polyvinyl butyral products, vitamin B5 and original B5. The company was founded on November 10, 2000 and is headquartered in Hangzhou, China.
www.yifanyy.comNo one on the platform currently holds 002019.SZ.
No tracked institution reports a position in 002019.SZ as of their last filing.
No one on the platform has traded 002019.SZ yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 3.7% | — | — | — | ||
| Rev. Growth % | -0.5% | -1.0% | ||||
| Profit Margin % | 7.8% | 2.6% | 11.4% | |||
| Free Cash Flow Margin % | -2.0% | -2.7% | 3.6% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $5.6B | -8.4% | $0.36 | $0.36–$0.36 | — | 1 |
| 2027 | $6.0B | +7.8% | $0.47 | $0.47–$0.47 | — | 1 |
| 2028 | $6.4B | +6.8% | $0.54 | $0.54–$0.54 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| 002019.SZYifan Pharmaceutical Co., Ltd. | $9.24 | -0.75% | $11.2B | — |
| 000999.SZChina Resources Sanjiu Medical & Pharmaceutical Co., Ltd. | $24.12 | -0.74% | $40.1B | — |
| 002001.SZZhejiang NHU Company Ltd. | $26.75 | -0.63% | $82.2B | — |
| 002007.SZHualan Biological Engineering Inc. | $12.86 | -1.61% | $23.5B | — |
| 002030.SZDaan Gene Co., Ltd. | $5.21 | -2.62% | $7.3B | — |
| 002038.SZBeijing SL Pharmaceutical Co., Ltd. | $5.57 | -1.94% | $5.7B | — |
| ALPMYAstellas Pharma Inc. | $14.86 | +0.07% | $26.6B | — |
Source: Financial Modeling Prep · peers by sector/industry